MMR vaccine for use in community measles outbreaks: PGD template
Patient group direction (PGD) template to support the provision of MMR vaccine to individuals with a date of birth on or after 1 January 2020.
Applies to England
Documents
Details
This patient group direction (PGD) template supports the provision of measles, mumps and rubella (MMR) vaccine to individuals born on or after 1 January 2020 and who require urgent protection in an outbreak situation, as outlined in 3.5.4.4 (vaccine options) of the national measles guidelines v7.
MMR vaccine for use in community measles outbreak PGD version 1.0 is valid from 1 May 2026 to 31 March 2029.
Practitioners must not use the PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012).
This PGD template should be used with reference to the National measles guidelines and as directed by the local health protection team.